Corticale

Corticale operates at the intersection of neuroscience research tools, medical devices, bioengineering, and artificial intelligence. Its stated focus is not limited to a software BCI layer: the company combines CMOS-based neural probes, high-density recording and stimulation, wireless neural-data transmission, and neural-decoding algorithms with laboratory implementation and data-analysis services. That combination gives it a potentially differentiated position among specialist suppliers serving neuroscience laboratories and neurotechnology developers, particularly where customers need help moving from device installation to usable experimental workflows. Corticale appears smaller than scaled medical-device manufacturers, with an employee range of one to ten and four identified current positions, but its OEM orientation may allow it to serve other neurotechnology and medical-research companies rather than compete solely for end-user clinical demand. Its main strategic challenge is likely converting technically differentiated components into repeatable research and clinical deployments, an outcome not yet demonstrated by public commercial metrics.

Corticale’s development trajectory shows a transition from scientific formation to an integrated neurotechnology offering. Gian Nicola Angotzi joined the company’s identified leadership structure as Chief Scientific Officer on May 1, 2020, while the company’s formal founding date is recorded as Jan 1, 2021. Joseph Santella and Fabio Boi assumed CEO and CTO roles on Feb 1, 2021, indicating that commercial and engineering leadership were established early in the company’s operating history. The product set spans SiNAPS Neural Probes with 1,024 independent sensors per probe, wireless transmission capable of 600 Mbit/s, and AI/ML algorithms for interpreting neural-implant data. Website positioning adds CortiX analysis and hands-on laboratory support, suggesting an effort to broaden from component technology into a complete research workflow. With four identified current positions and no reported layoffs, the trajectory appears technically focused but difficult to quantify beyond product breadth and continued active status.